article · Nutrients
Type 2 diabetes represents an ongoing global health challenge, driving demand for complementary dietary strategies alongside standard pharmaceuticals. Blackcurrant, or Ribes nigrum, contains high levels of bioactive phytochemicals including anthocyanins, flavonols, and phenolic acids that demonstrate metabolic regulatory potential. Experimental findings indicate that blackcurrant influences glucose metabolism by inhibiting digestive enzymes such as alpha-amylase and alpha-glucosidase, regulating intestinal glucose transporters, and supporting insulin sensitivity via AMPK signalling and GLUT4 translocation. Furthermore, blackcurrant compounds may stimulate glucagon-like peptide-1 secretion, modify gut microbiota, and provide antioxidant and anti-inflammatory protection against beta-cell dysfunction. Clinical evidence in humans associates blackcurrant consumption with lower postprandial glycaemic and insulinaemic responses, alongside modest cardiometabolic biomarker improvements. Although current human trials face limitations in sample size, duration, and formulation consistency, blackcurrant shows promise as a multi-target dietary adjunct for managing and preventing type 2 diabetes.
Type 2 diabetes affects millions worldwide, and many patients face adverse effects or incomplete control from conventional drugs alone. Understanding how functional plant foods like blackcurrant regulate blood sugar through multiple biological pathways offers accessible options to support metabolic health. Validating these dietary adjuncts helps healthcare providers and individuals integrate evidence-based nutrition into routine diabetes prevention and long-term care.
The evidence supports developing blackcurrant as a functional food, nutraceutical ingredient, or dietary supplement for glycaemic control. Potential users include food and beverage manufacturers, nutraceutical companies, and individuals seeking dietary management for type 2 diabetes. However, translational application remains at an intermediate stage: while mechanistic evidence and early human trials demonstrate efficacy, wider commercial development requires addressing product formulation heterogeneity and completing larger, longer-term clinical studies.
AI-generated from the published abstract. Always read the original work before citing.
Diabetes mellitus is a pervasive global health crisis, with type 2 diabetes (T2D) representing the majority of cases. While conventional pharmacological therapies exist, suboptimal efficacy, adverse effects, and inadequate glycemic control in a substantial proportion of patients highlight the need for complementary strategies. There is growing scientific and clinical interest in plant-based functional foods, including Ribes nigrum L. (blackcurrant), which is rich in bioactive phytochemicals such as anthocyanins, flavonols, and phenolic acids. This review evaluates the antidiabetic and metabolic regulatory potential of blackcurrant, focusing on its multi-target mechanisms of action. Available experimental evidence suggests that blackcurrants may influence glucose metabolism through several mechanisms, including inhibition of carbohydrate-digesting enzymes (α-amylase and α-glucosidase), modulation of intestinal glucose transporters (SGLT1 and GLUT2), and potential modulation of insulin sensitivity involving AMPK signaling and GLUT4 translocation. In addition, blackcurrant constituents may stimulate glucagon-like peptide-1 (GLP-1) secretion, modulate gut microbiota composition, and exert antioxidant and anti-inflammatory effects that counteract key drivers of insulin resistance and β-cell dysfunction. Supporting human studies indicate that blackcurrant consumption has been associated with attenuation of postprandial glycemic and insulinemic responses and modest improvements in cardiometabolic biomarkers, although findings remain limited by study size, duration, and formulation heterogeneity. Overall, Ribes nigrum represents a promising dietary adjunct for the prevention and management of T2D through multi-target metabolic regulation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3390/nu18172852
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
